In the BioHarmony Drug Report Database

"Preview" Icon

Enoxaparin

Lovenox (enoxaparin sodium) is an oligosaccharide pharmaceutical. Enoxaparin sodium was first approved as Lovenox on 1993-03-29. It is used to treat myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, and thrombophlebitis amongst others in the USA. It has been approved in Europe to treat venous thromboembolism. The pharmaceutical is active against antithrombin-III.

 

Trade Name

 

Lovenox
 

Common Name

 

enoxaparin sodium
 

ChEMBL ID

 

CHEMBL1201476
 

Indication

 

myocardial infarction, postoperative complications, pulmonary embolism, thromboembolism, thrombophlebitis, unstable angina, venous thromboembolism
 

Drug Class

 

Heparin derivatives and low molecular weight (or depolymerized) heparins

Image (chem structure or protein)

Enoxaparin structure rendering